Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Debt / NOTE 1.000%11/1
-
Market price (% of par)
-
100.0%
-
Total 13F principal
-
$49,835,500
-
Principal change
-
+$341,000
-
Total reported market value
-
$49,938,000
-
Number of holders
-
18
-
Value change
-
+$366,667
-
Number of buys
-
2
-
Number of sells
-
11
Institutional Holders of ISIS PHARMACEUTICALS INC DEL - NOTE 1.000%11/1 as of Q3 2021
As of 30 Sep 2021,
ISIS PHARMACEUTICALS INC DEL - NOTE 1.000%11/1 was held by
18 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$49,835,500
in principal (par value) of the bond.
The largest 10 bondholders included
OAKTREE CAPITAL MANAGEMENT LP, BNP Paribas Asset Management Holding S.A., Polygon Management Ltd., DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main, TENOR CAPITAL MANAGEMENT Co., L.P., Russell Investments Group, Ltd., PALISADE CAPITAL MANAGEMENT LLC/NJ, MORGAN STANLEY, Castle Creek Arbitrage, LLC, and WELLS FARGO & COMPANY/MN.
This page lists
18
institutional bondholders reporting positions
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.